Evidence map›Paper›PMID 32161302›Full record

ArticleScientific reports2020

Impact of indoor residual spraying with pirimiphos-methyl (Actellic 300CS) on entomological indicators of transmission and malaria case burden in Migori County, western Kenya.

Bernard Abong'o, John E Gimnig, Stephen J Torr, Bradley Longman, Diana Omoke, Margaret Muchoki, Feiko Ter Kuile, Eric Ochomo, Stephen Munga, Aaron M Samuels and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Insecticide resistance intensity inCurrent research in parasitology & vector-borne diseases · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Bernard Abong'oAbt Associates, PMI VectorLink Project, White House, Milimani, Ojijo Oteko Road, P.O. Box 895-40123, Kisumu, Kenya. abongoben@gmail.com.ORCID http://orcid.org/0000-0002-5038-604X
John E GimnigDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA.
Stephen J TorrLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Bradley LongmanAbt Associates, PMI VectorLink Project, White House, Milimani, Ojijo Oteko Road, P.O. Box 895-40123, Kisumu, Kenya.
Diana OmokeAbt Associates, PMI VectorLink Project, White House, Milimani, Ojijo Oteko Road, P.O. Box 895-40123, Kisumu, Kenya.
Margaret MuchokiAbt Associates, PMI VectorLink Project, White House, Milimani, Ojijo Oteko Road, P.O. Box 895-40123, Kisumu, Kenya.
Feiko Ter KuileLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.ORCID http://orcid.org/0000-0003-3663-5617
Eric OchomoCentre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya.
Stephen MungaCentre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya.
Aaron M SamuelsDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA.
Kiambo NjagiKenya National Malaria Control Programme (NMCP), Ministry of Health, PO Box 19982, Kenyatta National Hospital, Nairobi, 00202, Kenya.
James MaasLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Robert T PerryThe United States Presidents Malaria Initiative (PMI), US Embassy Nairobi, United Nations Avenue, Nairobi, Kenya.
Christen FornadelThe United States Presidents Malaria Initiative (PMI), US Agency for International Development, Washington, DC, USA.
Martin J DonnellyLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Richard M OxboroughPMI VectorLink Project, Abt Associates 6130 Executive Blv, Rockville, MD, 20852, USA.
Liverpool School of Tropical Medicine · GBThe White House · USCenters for Disease Control and Prevention · USKenya Medical Research Institute · KEKenyatta National Hospital · KEUnited Nations · USU.S. President's Malaria Initiative · USVector (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indoor residual spraying (IRS) of insecticides is a major vector control strategy for malaria prevention. We evaluated the impact of a single round of IRS with the organophosphate, pirimiphos-methyl (Actellic 300CS), on entomological and parasitological parameters of malaria in Migori County, western Kenya in 2017, in an area where primary vectors are resistant to pyrethroids but susceptible to the IRS compound. Entomological monitoring was conducted by indoor CDC light trap, pyrethrum spray catches (PSC) and human landing collection (HLC) before and after IRS. The residual effect of the insecticide was assessed monthly by exposing susceptible An. gambiae s.s. Kisumu strain to sprayed surfaces in cone assays and measuring mortality at 24 hours. Malaria case burden data were extracted from laboratory records of four health facilities within the sprayed area and two adjacent unsprayed areas. IRS was associated with reductions in An. funestus numbers in the intervention areas compared to non-intervention areas by 88% with light traps (risk ratio [RR] 0.12, 95% CI 0.07-0.21, p < 0.001) and 93% with PSC collections (RR = 0.07, 0.03-0.17, p < 0.001). The corresponding reductions in the numbers of An. arabiensis collected by PSC were 69% in the intervention compared to the non-intervention areas (RR = 0.31, 0.14-0.68, p = 0.006), but there was no significant difference with light traps (RR = 0.45, 0.21-0.96, p = 0.05). Before IRS, An. funestus accounted for over 80% of Anopheles mosquitoes collected by light trap and PSC in all sites. After IRS, An. arabiensis accounted for 86% of Anopheles collected by PSC and 66% by CDC light trap in the sprayed sites while the proportion in non-intervention sites remained unchanged. No sporozoite infections were detected in intervention areas after IRS and biting rates by An. funestus were reduced to near zero. Anopheles funestus and An. arabiensis were fully susceptible to pirimiphos-methyl and resistant to pyrethroids. The residual effect of Actellic 300CS lasted ten months on mud and concrete walls. Malaria case counts among febrile patients within IRS areas was lower post- compared to pre-IRS by 44%, 65% and 47% in Rongo, Uriri and Nyatike health facilities respectively. A single application of IRS with Actellic 300CS in Migori County provided ten months protection and resulted in the near elimination of the primary malaria vector An. funestus and a corresponding reduction of malaria case count among out-patients. The impact was less on An. arabiensis, most likely due to their exophilic nature.

Indexed as

Insect ControlAnimalsDisease VectorsEntomologyGeography, MedicalHumansInsecticidesKenyaMalariaOrganothiophosphorus CompoundsSeasonsInsecticidesOrganothiophosphorus Compoundspirimiphos methyl

Identifiers

PMID32161302
PMCPMC7066154
OpenAlexW3012208139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.